Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ridge

Showing results (251-260 of 346) with videos related to

Pageof 35
Sort By:
Head & Neck|June 28, 2013
Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancerCarolyn Y Fang, Brian L Egleston, John A Ridge, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Cancer Immunology Research|April 5, 2018
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer MetastasesMichael S Magee, Tara S Abraham, Trevor R Baybutt, et al.
British Journal of Anaesthesia|May 14, 2022
Use of sildenafil in patients with severe COVID-19 pneumonitisCharles McFadyen, Ben Garfield, Jennifer Mancio, et al.
Head & Neck|January 18, 2012
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil, Anamaria Reyna Yeung, Madhur Kumar Garg, et al.
Oral Oncology|June 14, 2011
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck, Joseph K Salama, Nabil Saba, et al.
Head & Neck|February 7, 2013
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancerMadhur K Garg, John A Ridge, Sue S Yom, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)Andy Trotti, Qiang Zhang, Søren M Bentzen, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Pageof 35

Showing results (251-260 of 346) with videos related to

Sort By:
Pageof 35
Head & Neck|June 28, 2013
Psychosocial functioning and vascular endothelial growth factor in patients with head and neck cancerCarolyn Y Fang, Brian L Egleston, John A Ridge, et al.
Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.
Cancer Immunology Research|April 5, 2018
Human GUCY2C-Targeted Chimeric Antigen Receptor (CAR)-Expressing T Cells Eliminate Colorectal Cancer MetastasesMichael S Magee, Tara S Abraham, Trevor R Baybutt, et al.
British Journal of Anaesthesia|May 14, 2022
Use of sildenafil in patients with severe COVID-19 pneumonitisCharles McFadyen, Ben Garfield, Jennifer Mancio, et al.
Head & Neck|January 18, 2012
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil, Anamaria Reyna Yeung, Madhur Kumar Garg, et al.
Oral Oncology|June 14, 2011
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck, Joseph K Salama, Nabil Saba, et al.
Head & Neck|February 7, 2013
Reply, contralateral irradiation for T(limited)N2bM0 lateralized tonsil cancerMadhur K Garg, John A Ridge, Sue S Yom, et al.
International Journal of Radiation Oncology, Biology, Physics|July 19, 2014
Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)Andy Trotti, Qiang Zhang, Søren M Bentzen, et al.
Head & Neck|March 5, 2004
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollmentRobert A Schnoll, Randi L Rothman, Caryn Lerman, et al.
Pageof 35